In contrast, ERK1/2 phosphorylation was significantly downregulated in patients with DCM, IHD and IHD-T2DM compared to non-failing controls, whereas deterioration in LV systolic function (EF) was associated with the reduction in the activating phosphorylation of ERK1/2. This evidence concerns the gene MAPK3 and familial dilated cardiomyopathy.